UARK 2003-33, Total Therapy III
Completed · Phase 2
Conditions studied: Multiple Myeloma
In brief
There have been two previous Total Therapy studies for multiple myeloma (MM) at the Myeloma Institute for Research and Therapy (MIRT): Total Therapy I (from 1989 through 1994) and Total Therapy II (from 1996 to 2004). Results have shown that patients treated on these studies had better outcomes (meaning patients have lived longer and had better responses to treatment) when compared to patients treated with standard chemotherapy. With this new study, Total Therapy III, researchers will take what they have learned from the first two studies and add new treatment strategies to try to improve the outcomes even more, especially for patients with chromosome abnormalities.
Key facts
- Study ID
- NCT00081939
- Run by
- University of Arkansas
- People needed
- 303
- Starts
- 2004-01-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2017-10-17
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arkansas for Medical Sciences/MIRT — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.